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ABSTRACT  
Numerous studies on glutamine metabolism in cancer demonstrate that glutamic acid and glutamine analogues may be developed as possible 
antitumor agent. Efforts were made to synthesize glutamamide analogues, structure variants of glutamic acid and glutamine contains both the 
amido groups at position of glutamic acid and derivative of both glutamine and is glutamine. Glutamic acid is a natural dicarboxylic amino 
acid having, alone or in his derivatives, valuable antimetabolic, antimicrobial and antifungal properties. Also, this compound is considered to 
be useful for the future treatment of neurological conditions, ulcers, hypoglycemic coma, muscular dystrophy, epilepsy, Parkinson’s disease 
and mental retardation.  
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INTRODUCTION 
Tumors  have  been  described  as  nitrogen  trap
1,2.  It 
requires  continuous  supply  of  both  essential  and 
nonessential amino acid as nitrogen source for increased 
biosynthesis of nucleic acid and protein- the two most 
essential  components  of  genomics  and  proteomics. 
Glutamine is the most abundant free amino acid in the 
human body and, therefore, plays a key role in tumor cell 
growth  by  supplying  its  amide  nitrogen  atom  in  the 
biosynthesis of other amino acids, purine and pyrimidine 
bases
3  via a  family  comprised of 16 amidotransferases 
with diversified mechanisms
4. It is one of the two, if not 
the only, major substrate of cancer
5. Thus, tumors indeed 
behave as glutamine traps. The tumor growth causes a 
change  in  host  glutamine  metabolism  so  that  host 
nitrogen  metabolism  is  accommodated  to  the  tumor-
enhanced requirements of glutamine
6. To be used in this 
process,  glutamine  must  reach  into  mitochondria  of 
tumor  cells  through  plasma  membrane  and  inner 
mitochondrial  membrane  transporters.  Glutamine  also 
plays  an  important  function  in  multiple  metabolic 
pathways and an important component in the cell culture 
media for both carbon and nitrogen source
7. All of the 
tumor  cells  studied  so  far  had  a  high  activity  of 
phosphate dependent glutaminase. These were found to 
utilized glutamine from the culture medium during long 
term  culture.  Rates  of  cell  growth,  DNA  and  protein 
synthesis as well as thymidine transport were correlated 
with the glutamine concentration in the culture media
8. 
Cell  growth  is  a  function  of  glutamine  influx  and 
suggests that glutamine is used to supply glutaminate and 
cytine perhaps  for glutathione synthesis
9. The reported 
antagonists of glutamine e.g. Azaserine, 6-diazo-5-oxo-
L-norleucin (DON) and Acivicin are potent inhibiters of 
glutamine dependent amidotransferases
10. 
Glutamic  acid  is  a  natural  dicarboxylic  amino  acid 
having,  alone  or  in  his  derivatives,  valuable 
antimetabolic,  antimicrobial  and  antifungal  properties. 
Also, this compound is considered to be useful for the 
future  treatment  of  neurological  conditions,  ulcers, 
hypoglycemic  coma,  muscular  dystrophy,  epilepsy, 
Parkinson’s disease and mental retardation
11.   
CHEMISTRY 
Synthesis  of  N-(p-methoxy  benzene  sulphonyl) 
glutamamides was carried out according to structure
12. 
Neucleophillic displacement of intermediate with amines 
(amino-dehydroxylation)  evolved  the  corresponding 
amides.  
Synthesis  was  started  with  chlorosulphonylation  of 
substituted  benzene  (p-methoxy  benzene)  to  get 
corresponding sulphonyl chlorides. These halides prove 
to  be  versatile  synthon  in  the  subsequent  step  for  the 
preparation  of  substituted  benzenesulphonyl  glutamic 
acid. P-methoxy benzene sulphonyl-L-glutamic acid was 
prepared by condensation reaction with L-glutamic acid. 
In  this  reaction  alkaline  medium  was  maintained  to 
remove  the  hydrochloric  acid,  which  is  formed  during 
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thionyl chloride afforded the acyl chlorides, p-methoxy 
benzene sulphonyl-L-glutamic acid dichloride
13.  
       
SO2NH CH3O
CONHR RNHOC  
QSAR STUDY 
Quantitative  Structure-Activity  Relationship  has  been 
performed  on  the  anticancer  activity  of  1,  5-N,  N’- 
disubstituted-2-(substituted  benzenesulphonyl) 
glutamamides  using  electro  topological  state  atom  (E-
state)  indices,  refract  topological  state  atom  (R-state) 
indices
 13-14. 
PHARMACOLOGY 
Anti cancer activity 
The  1,  5-N,  N’-disubstituted-2-(substituted 
benzenesulphonyl)  glutamamides  were  biologically 
screened  for  their  possible  anticancer  activity  against 
Ehrlich Ascites Carcinoma (EAC) cell in Swiss Albino 
mice. 
Ehrlich  Ascites  carcinoma  (EAC)  cell  were  originated 
from  human  breast  carcinoma.  EAC  cell  were 
maintained in vivo in Swiss Albino mice, by passaging 
every 10 days. EAC cell of 9 days old were used for the 
screening of the compounds
13. 
The  1,  5-N,  N’-disubstituted-2-(substituted 
benzenesulphonyl)  glutamamides  were  synthesized,  as 
tools for further elucidation of the structure requirement 
for antitumor activity. All the synthesis compounds were 
tested  for  antitumor  activity  against  Ehrlich  Ascites 
Carcinoma  (EAC)  in  Swiss  albino  mice  using  tumor 
weight as inhibitory paramrter
14.  
The study also shows that the increasing molar volumes 
of these analogues have advantageous effect to antitumor 
activity
15-16.  
FUJITA- BAN ANALYSIS 
In the QSAR study using Fujita-Ban model, the structure 
of  1,  5-N,  N’-disubstituted-2-(substituted 
benzenesulphonyl)  glutamamides  was  used.  Biological 
activities  along  with  the  substituent  types  of  the 
glutamamide analogs are given. The method used in this 
study  is  a  modification  of  the  Free-Wilson  technique. 
Here, the log of activity is considered to be a free energy 
related parameter which is additive in nature. Fujita and 
Ban  in  1971  derived  a  linear  equation  for  a  set  of 
substituent, in the form equation which is as follows:
 17 
  Log BA=∑GiXi + µ 
CONCLUSION 
The  above  compounds  have  been  synthesized, 
characterized  and  evaluated.  The  designing  of  the 
compounds synthesized for this research work was based 
on biochemical rationale, now the most active molecule 
of  the  series  will  be  predicted  and  its  QSAR  study  is 
done.  Based  on  regression  analysis,  substituents  in 
different  compounds  are  chosen,  which  suggest  that 
glutamamide derivative have excellent scope for further 
development  as  commercial  anticancer  agent.  The 
present work upholds the additive nature of Fajita –Ban 
analysis and can be used as a good model by overcoming 
limitations. 
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